British Biosimilars Association

The British Biosimilars Association (BBA), has launched today (19 April) with the sole focus of increasing the understanding and use of biosimilar medicines in the UK.

As an expert sector group of the British Generic Manufacturers Association (BGMA), the BBA will work to give patients in the UK the same access to lifesaving and life changing biosimilar medicines as elswhere in Europe. Currently, the UK lags behind some European countries in the take-up of biosimilar medicines. Restricting patient access to these medicines costs the NHS money that could be used for other treatments.

Biological medicines are protein based and made or derived from living organisms. They can be tailor made so they bind to specific targets in the body, which is not possible with conventional medicines. A biosimilar medicine is manufactured to be similar to an existing licensed “reference” biological medicine after expiry of its patent, with no meaningful differences in terms of quality, safety or efficacy.

Currently, there are seven biosimilar molecules on the market in the UK but this is set to increase due to various factors including patent expiries, increasing clinical awareness and supportive guidance from NICE.

Keith Ridge, NHS England’s chief pharmaceutical officer, said: “We very much welcome the creation of the British Biosimilars Association with its clear focus on providing information about these vitally important medicines. Biosimilar medicines have enormous potential to deliver increased patient access as well as savings to the NHS which can be reinvested elsewhere.

"It is important that clinicians are aware of their potential and that wherever appropriate biosimilar competition is encouraged. We look forward to continuing to work with the BBA and its members to that end.”


Recommended

Scotland’s CPO to address NPA/PM conference

Little change in gender pay gap at the multiples




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.